Literature DB >> 7686741

Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents.

T Sodeyama1, K Kiyosawa, A Urushihara, A Matsumoto, E Tanaka, S Furuta, Y Akahane.   

Abstract

BACKGROUND: Needlestick accidents are a problem among health care workers. Using sensitive new assays, we evaluated the prevalence and features of hepatitis C virus (HCV) infection following a needlestick accident.
METHOD: The clinical outcome and evolution of serum HCV markers were assessed in 90 hospital employees (recipients) who sustained needlestick injuries (selected from 146 episodes) involving 92 patients with clinical non-A, non-B hepatitis (donors).
RESULTS: Of the 92 patient donors, 62 (67%) and 88 (96%) were anti-C100-3 and second-generation anti-HCV positive, respectively, at the time of the needlestick accident. During the follow-up period (> or = 6 months), acute non-A, non-B hepatitis developed in three of 90 recipients about 1 month after the accident. The three respective donors were positive for serum HCV-RNA at the time of the accident. Two of the three recipients became HCV-RNA positive just after the onset of hepatitis, and subsequently, HCV antibodies developed. None of the remaining 87 recipients had any clinical or laboratory evidence of hepatitis during follow-up, or experienced seroconversion for anti-C100-3 or second-generation anti-HCV. We measured additional HCV markers in 20 of the 89 donors; 16 had evidence of HCV infection (HCV-RNA). However, none of the respective recipients of any of these 20 became positive for HCV markers during follow-up.
CONCLUSION: Although transmission of HCV infection by needlestick injury may be infrequent, such transmission does occur. Appropriate precautions should be taken to protect health care workers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686741

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

1.  [Postexposure prevention after occupational exposure to HBV, HCV and HIV].

Authors:  U Sarrazin; R Brodt; C Sarrazin; S Zeuzem
Journal:  Urologe A       Date:  2003-11       Impact factor: 0.639

2.  Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.

Authors:  Jason Grebely; Gregory J Dore
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

Review 3.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Testing healthcare staff for infection with HIV and hepatitis: logistic and ethical considerations.

Authors:  A Newell; S E Barton
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

Review 5.  Risk and management of blood-borne infections in health care workers.

Authors:  E M Beltrami; I T Williams; C N Shapiro; M E Chamberland
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 6.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 7.  Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing.

Authors:  Susanna Naggie; David P Holland; Mark S Sulkowski; David L Thomas
Journal:  Clin Infect Dis       Date:  2016-09-28       Impact factor: 9.079

Review 8.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

9.  Occupational hepatitis C virus infection in Italian health care workers. Italian Study Group on Occupational Risk of Bloodborne Infections.

Authors:  V Puro; N Petrosillo; G Ippolito; M S Aloisi; E Boumis; L Ravà
Journal:  Am J Public Health       Date:  1995-09       Impact factor: 9.308

Review 10.  [Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?].

Authors:  A Kubitschke; C Bader; H L Tillmann; M P Manns; S Kuhn; H Wedemeyer
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.